Latigo Biotherapeutics, Inc. (NasdaqGS: LTGO)
Health Care · Pharmaceuticals · US
$13.11
+1.39% today · -28.2% 1Y
Latigo Biotherapeutics, Inc. (NasdaqGS: LTGO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $869.18M and employs 66 people.
Over the last twelve months the share price has lost 28.2%, trading between 12.60 and 25.93.
Tweenvest scores Latigo Biotherapeutics, Inc. across four factors: quality 44/100, value 100/100. Its strongest factor is value.
LTGO price history
Key figures
- Market cap
- $869.18M
- Revenue (TTM)
- —
- P/E
- -7.82
- EPS
- -6.86
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $25.93
- 52-week low
- $12.60
- Avg volume (3M)
- —
- Shares outstanding
- 66.30M
- Employees
- 66
- Next earnings
- —
About Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
- ISIN
- US5179541033
- Founded
- 2018
- Listed since
- Aug 7, 2026
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Alebund Pharmaceuticals (Jiangsu) LimitedSEHK: 9637 | $892.36M | HK$20.60 | -2.92% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd.SHSE: 600771 | $886.49M | CN¥12.09 | -2.11% |
| Dezhan Healthcare Company LimitedSZSE: 000813 | $879.67M | CN¥2.80 | -2.78% |
| Hunan Warrant Pharmaceutical Co.,LtdSHSE: 688799 | $875.28M | CN¥43.72 | -6.14% |
| Guizhou Bailing Group Pharmaceutical Co., Ltd.SZSE: 002424 | $867.05M | CN¥4.24 | -2.97% |
| Cisen Pharmaceutical Co., Ltd.SHSE: 603367 | $864.12M | CN¥12.74 | -0.23% |
| Daewoong Pharmaceutical Co., LtdKOSE: A069620 | $862.36M | ₩99,900.00 | +2.36% |
| Sanofi Consumer Healthcare India LimitedNSEI: SANOFICONR | $861.73M | Rs3,494.50 | -1.07% |